<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen G</submitter><funding>NEI NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>974-980</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6778035</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(10)</volume><pubmed_abstract>Delivery technologies for the CRISPR-Cas9 (CRISPR, clustered regularly interspaced short palindromic repeats) gene editing system often require viral vectors, which pose safety concerns for therapeutic genome editing&lt;sup>1&lt;/sup>. Alternatively, cationic liposomal components or polymers can be used to encapsulate multiple CRISPR components into large particles (typically >100 nm diameter); however, such systems are limited by variability in the loading of the cargo. Here, we report the design of customizable synthetic nanoparticles for the delivery of Cas9 nuclease and a single-guide RNA (sgRNA) that enables the controlled stoichiometry of CRISPR components and limits the possible safety concerns in vivo. We describe the synthesis of a thin glutathione (GSH)-cleavable covalently crosslinked</pubmed_abstract><journal>Nature nanotechnology</journal><pubmed_title>A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing.</pubmed_title><pmcid>PMC6778035</pmcid><funding_grant_id>R01 HL129785</funding_grant_id><funding_grant_id>R01 NS091540</funding_grant_id><funding_grant_id>R01 EY024995</funding_grant_id><funding_grant_id>R35 GM119644</funding_grant_id><funding_grant_id>UG3 NS111688</funding_grant_id><funding_grant_id>R01 HL143469</funding_grant_id><pubmed_authors>Robertson S</pubmed_authors><pubmed_authors>Gong S</pubmed_authors><pubmed_authors>Suzuki M</pubmed_authors><pubmed_authors>Shahi PK</pubmed_authors><pubmed_authors>Chen G</pubmed_authors><pubmed_authors>Abdeen AA</pubmed_authors><pubmed_authors>Pattnaik BR</pubmed_authors><pubmed_authors>Saha K</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Xie R</pubmed_authors></additional><is_claimable>false</is_claimable><name>A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing.</name><description>Delivery technologies for the CRISPR-Cas9 (CRISPR, clustered regularly interspaced short palindromic repeats) gene editing system often require viral vectors, which pose safety concerns for therapeutic genome editing&lt;sup>1&lt;/sup>. Alternatively, cationic liposomal components or polymers can be used to encapsulate multiple CRISPR components into large particles (typically >100 nm diameter); however, such systems are limited by variability in the loading of the cargo. Here, we report the design of customizable synthetic nanoparticles for the delivery of Cas9 nuclease and a single-guide RNA (sgRNA) that enables the controlled stoichiometry of CRISPR components and limits the possible safety concerns in vivo. We describe the synthesis of a thin glutathione (GSH)-cleavable covalently crosslinked</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2025-04-04T00:05:20.669Z</modification><creation>2020-05-22T12:16:01Z</creation></dates><accession>S-EPMC6778035</accession><cross_references><pubmed>31501532</pubmed><doi>10.1038/s41565-019-0539-2</doi></cross_references></HashMap>